Dr. Ami Shah, MD
Claim this profileNorthwestern University
Studies Breast Cancer
Studies Breast cancer
6 reported clinical trials
10 drugs studied
Area of expertise
1Breast Cancer
Stage IV
BRCA1 positive
BRCA2 positive
2Breast Cancer
Stage IV
HER2 negative
HER2 positive
Affiliated Hospitals
Clinical Trials Ami Shah, MD is currently running
Talazoparib
for Breast Cancer
This trial is testing talazoparib, a drug that may help treat breast cancer that has spread and has specific genetic mutations (BRCA 1 or BRCA 2). Talazoparib works by stopping proteins that repair DNA, making it harder for cancer cells to survive. The goal is to see if this drug can reduce tumor size and slow down cancer growth in these patients. Talazoparib is a new treatment recently approved for use in patients with metastatic breast cancer with germline BRCA mutations.
Recruiting1 award Phase 218 criteria
Sacituzumab Govitecan
for Brain Metastases from Breast Cancer
This phase II trial studies the effect of sacituzumab govitecan in treating patients with HER2-negative breast cancer that has spread to the brain (brain metastases). Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted therapy because it attaches to specific molecules on the surface of cancer cells, known as Trop-2 receptors, and delivers govitecan to kill them. Giving sacituzumab govitecan may shrink the cancer in the brain and/or extend the time until the cancer gets worse.
Recruiting1 award Phase 212 criteria
More about Ami Shah, MD
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Ami Shah, MD has experience with
- Talazoparib
- Gedatolisib
- Belumosudil (KD025)
- Placebo
- Docetaxel
- Paclitaxel
Breakdown of trials Ami Shah, MD has run
Breast Cancer
Breast cancer
Skin Cancer
Multiple sclerosis
Systemic Sclerosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ami Shah, MD specialize in?
Ami Shah, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Ami Shah, MD currently recruiting for clinical trials?
Yes, Ami Shah, MD is currently recruiting for 2 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Ami Shah, MD has studied deeply?
Yes, Ami Shah, MD has studied treatments such as Talazoparib, Gedatolisib, Belumosudil (KD025).
What is the best way to schedule an appointment with Ami Shah, MD?
Apply for one of the trials that Ami Shah, MD is conducting.
What is the office address of Ami Shah, MD?
The office of Ami Shah, MD is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.